Power Law company profile

Viome

Biotech & Life Sciences · Bellevue, United States · Founded 2016 Colt

Provides the industry’s only direct-to-consumer healthcare test that analyzes microbial and human gene expressions (mRNA)

Valuation

$100–500M

Latest valuation · 2026

Unlock exact value

Revenue

$10–50M

Latest reported FY

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

8 investors on Viome's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

Khosla Ventures

Bold Capital Partners

Series B+ 6 investors entered at this stage

Physician Partners

Ocgrow Group of Companies

Marc Benioff

WestRiver Group

Ezaki Glico

Bold Capital

Global footprint

Where Viome has talent and traffic

AI talent share

4.4% of workforce is AI talent
(4 of 91 staff)

Core AI00%

Other AI44.4%

Non-AI workforce8795.6%

Workforce by country

🇺🇸 United States · Bellevue HQ

Book a demo for the full country breakdown

Web traffic by country

200K monthly visits
across markets

🇺🇸 United States60.5%

🇮🇳 India17.9%

🇬🇧 United Kingdom3.8%

🇨🇦 Canada3.4%

🇦🇺 Australia1.6%

Top 5 markets shown

Market sentiment

What the market is saying about Viome

An AI-synthesized read of the highest-engagement posts about Viome on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Viome on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles